Markel Corporation Profile Avatar - Palmy Investing

Markel Corporation

Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, Bermuda, the United Kingdom, rest of Europe, Canada, the Asia Pacific, and the Middle East. Its Insurance segment offers g…
Insurance - Property & Casualty
US, Glen Allen [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -45.91 -1075.01 -736.78
Graham Fair Price 19.22 1449.96 1216.19
PEG 1853.04 0.15 < 0.005
Price/Book 0.42 1.26 1.25
Price/Cash Flow 35.66 35.48 26.15
Prices/Earnings -20.89 4.83 6.11
Price/Sales 9.57 4.44 4.05
Price/FCF 35.66 35.48 26.15
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 13.10 1.12 0.99
Operating Margin 5310.25 0.30 < 0.005
ROA 28.86 0.02 0.02
ROE 0.05 0.07 26.94
ROIC < 0.005 0.05 4877.34
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.13 0.18 -26.02
Dividends QOQ 0.00 -1.00 -100.00
EBIT QOQ -1.35 53.05 3822.73
EPS QOQ 8.23 0.33 -95.95
FCF QOQ -0.18 -0.22 -21.85
Revenue QOQ 0.38 -0.04 -89.91
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) -46584.87 1213.12 -97.40
Days Sales Outstanding (DSO) 246.02 265.65 7.98
Inventory Turnover < 0.005 0.07 3740.09
Debt/Capitalization 0.21 0.20 -4.79
Quick Ratio 1.34 1.34 0.03
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 1131.55 1197.36 5.82
Cash 610.39 607.88 -0.41
Capex -7.82 -5.48 29.95
Free Cash Flow 54.30 42.53 -21.67
Revenue 350.59 340.01 -3.02
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.74 0.73 -1.36
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -4.09 23.34 470.61
Naive Interpretation Member
06 - Financial Health · Bad
End of MKL's Analysis
CIK: 1096343 CUSIP: 570535104 ISIN: US5705351048 LEI: - UEI: -
Secondary Listings
MKL has no secondary listings inside our databases.